Tevogen Bio Inc.

0.98
-0.01 (-1.23%)
Apr 28, 2025, 12:51 PM - Market open
-1.23%
Created with Highcharts 11.4.39 AM4 PM10 AM12 PM1 PM2 PM0.9811.02
Bid 0.94
Market Cap 180.73M
Revenue (ttm) 396.59K
Net Income (ttm) -13.73M
EPS (ttm) -0.07
PE Ratio (ttm) -14.04
Forward PE n/a
Analyst Buy
Ask 1.03
Volume 122,470
Avg. Volume (20D) 690,118
Open 0.99
Previous Close 0.99
Day's Range 0.98 - 1.00
52-Week Range 0.26 - 3.09
Beta -0.82

About TVGN

Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey....

Industry Biotechnology
Sector Healthcare
IPO Date Jan 5, 2022
Employees 18
Stock Exchange NASDAQ
Ticker Symbol TVGN
Full Company Profile

Analyst Forecast

According to 1 analyst ratings, the average rating for TVGN stock is "Buy." The 12-month stock price forecast is $10, which is an increase of 917.50% from the latest price.

Created with Highcharts 11.4.3StrongSellSellHoldBuyStrongBuy012
Price Target: $10
(917.50% upside)
Analyst Consensus: Buy
Stock Forecasts
1 month ago
+7.63%
Tevogen Bio Holdings shares are trading higher aft... Unlock content with Pro Subscription
3 months ago
+24.44%
Tevogen Bio shares are trading higher after the company announced an AI collaboration with Microsoft.